EUVIMEDEUVIMED entdecken
Open Access

The Impact of Lymphoscintigraphy Visualization on the Prognosis of Early Breast Cancer Patients Undergoing Sentinel Node Biopsy: A 20‐year, Single‐center Experience

Hui Ying Khoo, Masami Tsukabe, Yoshiaki Sota, Ryu Tokui, Chieko Mishima, Tetsuhiro Yoshinami, Nanae Masunaga, Tomonori Tanei, Kenzo Shimazu

Cancer Diagnosis & Prognosis · 01.07.2025 · 5 (4) · 506-514

DOI: 10.21873/cdp.10465 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Diagnosis & Prognosis, online erschienen am 01.07.2025. Verfasst von Hui Ying Khoo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast and Endocrine Surgery, Graduate School of Medicine, The University of Osaka, Suita, Japan. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Aim: Patients with early breast cancer typically have a relatively favorable prognosis, although recurrence still occurs in some cases. We hypothesized that nonvisualized lymphoscintigraphy (nonvLSG) during sentinel lymph node biopsy (SLNB) might signal lymphatic obstruction caused by tumor burden, potentially leading to poorer overall survival (OS) and relapse-free survival (RFS). Patients and Methods: This single-center retrospective cohort study included 247 patients with early breast cancer who underwent SLNB (between 1999 and 2003). Patients were grouped into visualized lymphoscintigraphy (vLSG) and nonvLSG cohorts. Clinical characteristics, SLNB outcomes, and survival data were analyzed over a median follow-up of 12.2 years (4 months-24 years). RFS and OS were compared using Kaplan‒Meier (K-M) and Cox regression analyses.

Results

Of the 247 patients, 223 (90.3%) had a vLSG, whereas 24 (9.7%) had a nonvLSG. Hormone receptor positivity was lower in the nonvLSG group (62.5% vs. 80.3%, p=0.03). K‒M survival analyses revealed no significant differences in OS or RFS between the vLSG and nonvLSG groups. Regarding OS, the log-rank test yielded p=0.927, and for RFS, p=0.762, indicating similar survival outcomes between the groups. At 20 years, estimated OS probabilities were 75% for the visualized group and 70% for the nonvisualized group, and RFS probabilities were approximately 70% for both groups.

Conclusion

Lymphoscintigraphy visualization status was not significantly associated with OS and RFS in patients with early breast cancer undergoing SLNB. This suggests that nonvisualization does not indicate a greater tumor burden or poorer prognosis. Clinically, this reassures that treatment strategies do not need to be adjusted solely based on nonvisualization in lymphoscintigraphy.

Schlagwörter

Stichwörter der Autor:innen

Non-visualized lymphoscintigraphyearly breast cancer prognosissentinel lymph node biopsy

Autor:innen und Institutionen

  • Department of Breast and Endocrine Surgery, Graduate School of Medicine, The University of Osaka, Suita, Japan.
  • Breast and Endocrine Unit, Surgical Department, Hospital Sultan Ismail, Johor, Malaysia.

Zitieren

APA

Khoo, H. Y., Tsukabe, M., Sota, Y., Tokui, R., Mishima, C., Yoshinami, T., Masunaga, N., Tanei, T., & Shimazu, K. (2025). The Impact of Lymphoscintigraphy Visualization on the Prognosis of Early Breast Cancer Patients Undergoing Sentinel Node Biopsy: A 20‐year, Single‐center Experience. Cancer Diagnosis & Prognosis, 5(4), 506-514. https://doi.org/10.21873/cdp.10465

Vancouver

Khoo HY, Tsukabe M, Sota Y, Tokui R, Mishima C, Yoshinami T, et al. The Impact of Lymphoscintigraphy Visualization on the Prognosis of Early Breast Cancer Patients Undergoing Sentinel Node Biopsy: A 20‐year, Single‐center Experience. Cancer Diagnosis & Prognosis. 2025;5(4):506-514. doi:10.21873/cdp.10465

BibTeX
@article{Khoo2025,
  author = {Khoo, Hui Ying and Tsukabe, Masami and Sota, Yoshiaki and Tokui, Ryu and Mishima, Chieko and Yoshinami, Tetsuhiro and Masunaga, Nanae and Tanei, Tomonori and Shimazu, Kenzo},
  title = {The Impact of Lymphoscintigraphy Visualization on the Prognosis of Early Breast Cancer Patients Undergoing Sentinel Node Biopsy: A 20‐year, Single‐center Experience},
  journal = {Cancer Diagnosis & Prognosis},
  year = {2025},
  volume = {5},
  number = {4},
  pages = {506--514},
  doi = {10.21873/cdp.10465}
}
Kostenlos starten →